PGF2alpha stimulates cardiomyocyte hypertrophy through tyrosine kinase and c-Jun NH2-terminal kinase pathways, rather than classical PKC, p38, or ERK pathways.
No takes yet. Share an insight, caveat, or question.
Highlights JNK/tyrosine kinase mediation of myocyte hypertrophy; hypothesis-generating and leaves open in vivo translation.
Adams et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: